Skip to main content
. 2024 Mar 7;16(6):1080. doi: 10.3390/cancers16061080

Figure 2.

Figure 2

Overall survival curves evaluated on the entire cohort of study patients subdivided based on presence/absence of the two prognostic factors: MELD > 9 and sarcopenia.